UK Innovation & Science Seed Fund

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Ikarovec is a gene therapy company focused on developing early-stage assets for the treatment of common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, including dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By targeting these conditions, Ikarovec seeks to provide effective treatments that restore sight and prevent blindness in patients.

Lineat is a manufacturer of fiber tape products. The company's carbon fiber tapes are manufactured using aligned formable fiber technology. It designed a closed-loop water circulation system to improve LCA.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Aquark Technologies develops atom systems to develop quantum applications, including atomic clocks, sensors, and navigation systems. Aquark develops a technique to miniaturize cold atom systems using unique laser geometry that is based on more than 10 years of proprietary research at the University of Southampton.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

HonuWorx is a technology company specializing in autonomous systems designed to enhance the efficiency and sustainability of robotic operations. The company's innovative software platform utilizes an edge-cloud architecture to facilitate communication and control among geographically distributed stakeholders, enabling them to monitor and manage robotic systems even when they are beyond line-of-sight. HonuWorx develops subsea robotics that support unmanned marine operations, significantly reducing dependence on large, costly manned vessels. By integrating off-the-shelf technologies, the company promotes lean operations and minimizes travel needs for offshore work, thereby aiding industries in restoring, exploring, and sustainably commercializing ocean resources.

Adamo Foods is a UK-based food technology company focused on developing plant-based whole-cut meats through innovative fermentation techniques and mycelium. The company aims to produce sustainable alternatives to traditional meat products, utilizing precision fermentation to create functional meat proteins. By harnessing fungal mycelium, Adamo Foods offers consumers an efficient, sustainable, and ethical way to enjoy meat-like experiences without sacrificing taste or quality.

MIRICO Ltd., based in Oxford, United Kingdom, specializes in developing advanced analytical instruments for trace gas analysis using unique Laser Dispersion Spectroscopy technology. Founded in 2015, the company focuses on providing high-performance gas sensing solutions that operate effectively in various weather conditions. MIRICO's offerings include stable isotope analyzers for applications such as space exploration and environmental monitoring, as well as real-time monitoring tools that utilize Tuneable Laser Absorption Spectroscopy and Laser Isotope Ratiometer techniques. These products enable industries to monitor emissions continuously and autonomously, facilitating the collection and interpretation of emissions data through a cloud platform. This technology aims to assist organizations in achieving net-zero emissions, improving operational efficiency, and gaining valuable insights into their activities. With a dedicated team of experts, MIRICO continues to set new standards in gas sensing for both industry and research professionals.

Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.

Presymptom Health develops a portfolio of clinical decision support algorithms and blood tests to enable early intervention and transform critical care outcomes.

ExactTrak is a cybersecuirty company that design and develop software for protecting mobil data on the move. The software is embedded into hardware such as USB memory products and directly into laptops. The company has a development agreement with a major processor manufacturer to embedded its technology into next generations of its professional processor range.

HutanBio is a biotechnology company focused on producing sustainable biofuels derived from algae. The firm offers HBx bio-oil, characterized by its high energy density, low carbon footprint, and sulfur-free composition. By developing scalable algal farms, HutanBio provides a drop-in replacement fuel that serves clients across various sectors, including marine, land, and aviation. This approach enables these industries to reduce their emissions and comply with environmental regulations, promoting a transition to cleaner energy solutions.

Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.

Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.

MitoRx Therapeutics is a biotechnology company that focuses on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company targets various conditions, including neuromuscular disorders, metabolic diseases, and dementia. By specializing in mitochondrial-protective therapies, MitoRx seeks to address the underlying causes of these challenging diseases. The company is committed to both developing treatments for rare indications and forming partnerships to tackle broader health issues. Through its efforts, MitoRx aims to enable healthcare professionals to halt the progression of conditions associated with dystrophy and neurodegeneration.

Laverock Therapeutics is focused on advancing gene silencing technology to create innovative programmable cell therapies. Their platform enables the engineering of next-generation allogeneic cell therapies that can adapt to both internal and external environmental signals. This capability allows for the development of induced pluripotent stem cell (iPSC)-derived products that offer enhanced efficacy, safety, and accessibility, addressing many of the challenges faced by traditional therapeutic methods. Through its pioneering approach, Laverock Therapeutics aims to facilitate significant advancements in the fields of medicine and biotechnology.

Pencil Biosciences is focused on creating an innovative genome modulation platform that addresses the limitations of existing gene-editing technologies. By developing a programmable tool for genome modulation, the company aims to provide new therapeutic options for patients suffering from rare diseases. This technology is designed to have a broad impact, allowing medical professionals to navigate the complexities of gene editing more effectively. Through its advancements, Pencil Biosciences seeks to enhance the capabilities of gene-editing applications in the medical field.

Laverock Therapeutics is focused on advancing gene silencing technology to create innovative programmable cell therapies. Their platform enables the engineering of next-generation allogeneic cell therapies that can adapt to both internal and external environmental signals. This capability allows for the development of induced pluripotent stem cell (iPSC)-derived products that offer enhanced efficacy, safety, and accessibility, addressing many of the challenges faced by traditional therapeutic methods. Through its pioneering approach, Laverock Therapeutics aims to facilitate significant advancements in the fields of medicine and biotechnology.

Mach42 is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.

twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.

CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases. CHAIN is developing several therapeutic compounds targeted to the gut microbiome in the large intestine that can be delivered by our CADD technology.

NK:IO is a biotechnology company focused on advancing natural killer cell-mediated immunotherapy, particularly in the realm of cancer treatment. The company specializes in developing innovative cell therapies and small molecule therapeutics designed to enhance the effectiveness of cancer targeting for physicians. By leveraging cutting-edge research and technology, NK:IO aims to improve treatment outcomes for patients facing cancer.

Resurrect Bio is a plant biotechnology company that will improve the immune systems of crop species to revolutionize the agricultural industry.

HydRegen is a biotechnology company based in Oxford, United Kingdom, founded in 2020. The company specializes in developing bio-based manufacturing technologies aimed at producing clean and sustainable chemicals. Utilizing biocatalysis, HydRegen offers innovative solutions that enhance agility, speed, and predictability during the early stages of industrial research and development. This approach enables the chemicals and pharmaceutical sectors to efficiently validate their processes while meeting essential requirements related to cost, productivity, and reproducibility on a large scale.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.

Silicon Microgravity Limited specializes in the development of advanced sensor devices tailored for the oil and gas sector. Founded in 2014 as a spin-out from Cambridge University, the company leverages sensor technology originally developed through a collaboration with BP. This technology enables the recording of gravity data at high sensitivities and seismic data at ultra-low frequencies, significantly enhancing the management of oil and gas reservoirs. By using microelectromechanical system sensors, Silicon Microgravity transforms the measurement of densities deep within reservoirs from boreholes. Additionally, its technology finds applications in navigation, guidance, and stabilization for various intelligent systems across commercial, industrial, and military sectors. The innovations provided by Silicon Microgravity aim to improve efficiency and reduce costs for clients while supporting their social, safety, and environmental objectives.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

Productive Machines that enable machining companies to be faster to the best part, first time, in an automated way. Unlike competitors who are stuck in a labour intensive iterative cycle to produce parts. Productive Machines have a digital twin of the physics, mechanics, dynamics, distortion and vibration of the machining process for metal cutting, enabling the company to test millions of parameters in simulation to enhance CAM and Gcode to improve productivity and part quality. Productive Machines is a spin out from the UK Advanced Manufacturing Research Centre (AMRC)

SugaROx specializes in the development of biostimulants that enhance agricultural productivity and resilience. Its products are designed to assist farmers in maximizing output from each unit of land while improving the overall sustainability of crop production. By addressing challenges such as drought and other adverse weather conditions, SugaROx aims to empower farmers to increase their productivity, profitability, and efficiency in crop systems.

Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.

MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy.

Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.

MIRICO Ltd., based in Oxford, United Kingdom, specializes in developing advanced analytical instruments for trace gas analysis using unique Laser Dispersion Spectroscopy technology. Founded in 2015, the company focuses on providing high-performance gas sensing solutions that operate effectively in various weather conditions. MIRICO's offerings include stable isotope analyzers for applications such as space exploration and environmental monitoring, as well as real-time monitoring tools that utilize Tuneable Laser Absorption Spectroscopy and Laser Isotope Ratiometer techniques. These products enable industries to monitor emissions continuously and autonomously, facilitating the collection and interpretation of emissions data through a cloud platform. This technology aims to assist organizations in achieving net-zero emissions, improving operational efficiency, and gaining valuable insights into their activities. With a dedicated team of experts, MIRICO continues to set new standards in gas sensing for both industry and research professionals.

Lineat is a manufacturer of fiber tape products. The company's carbon fiber tapes are manufactured using aligned formable fiber technology. It designed a closed-loop water circulation system to improve LCA.

MitoRx Therapeutics is a biotechnology company that focuses on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company targets various conditions, including neuromuscular disorders, metabolic diseases, and dementia. By specializing in mitochondrial-protective therapies, MitoRx seeks to address the underlying causes of these challenging diseases. The company is committed to both developing treatments for rare indications and forming partnerships to tackle broader health issues. Through its efforts, MitoRx aims to enable healthcare professionals to halt the progression of conditions associated with dystrophy and neurodegeneration.

Q5D is an innovative company that specializes in automating the manufacture and assembly of wiring looms and harnesses across various industrial sectors. By developing advanced laser micromachining technology, Q5D streamlines the intricate process of connecting electrical components. This technology enhances global manufacturing capabilities, particularly in consumer goods, electronics, automotive, aerospace, and robotics. By enabling the direct addition of wires and printed electronics to product surfaces, Q5D improves quality, productivity, and functionality while reducing manufacturing costs. As a result, the company provides its clients with a significant advantage in achieving efficiency, resilience, and sustainability in their operations.

Atheras Analytics specializes in developing AI-based software tools delivered as a service, aimed at enhancing the design and operation of Ka-band and Q/V-band satellite networks. The company's software utilizes machine learning algorithms derived from a comprehensive database of satellite signal propagation time-series measurements and high-resolution data. This innovative approach helps satellite operators mitigate the impact of weather on network performance, thereby improving overall service availability. By optimizing the design of multi-gateway satellite networks, Atheras Analytics enables operators to achieve more efficient and cost-effective solutions in the satellite communication industry.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

NanoSyrinx is a biotechnology company focused on developing an innovative system for the targeted delivery of therapeutic proteins and peptides directly into the cytosol of cells. By employing synthetic biology techniques, the company aims to create a groundbreaking method for drug delivery that enhances the efficacy, safety, and cost-effectiveness of treatments in the biopharmaceutical sector. This novel approach allows for precise delivery of therapeutic agents, potentially improving treatment outcomes for patients by ensuring that the drugs reach their intended cellular targets.

AgPlus Diagnostics have developed a diagnostic platform technology that will deliver against the demanding market requirements of a true quantitative PoC product for use across a wide range of clinical applications.

Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.

Cytoseek Limited, a spinout from the University of Bristol, develops innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Established in 2017 and based in Bristol, the company utilizes a novel cell membrane augmentation technology that enhances the functionality of cell therapies. This technology enables targeted tissue delivery and improves cell survivability, potentially increasing the efficacy of treatments. Cytoseek is currently conducting proof of principle studies to validate its approach and is actively seeking partnerships with other cell therapy companies to advance these therapies into clinical applications, ultimately striving to improve human health.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, founded in 2011. The company has developed a diagnostic platform that utilizes linear dichroism (LD) technology for a variety of applications, including the detection of antibiotic resistance in infections and testing for bacteria that cause food spoilage. This innovative platform enables simultaneous measurement of multiple targets in a single sample, employing various molecular recognition methods. Additionally, Linear Diagnostics offers a handheld reader specifically designed to measure LD signals. The technology provides significant advantages over conventional methods, facilitating rapid point-of-care tests for infectious diseases and addressing challenges related to antibiotic resistance while aiming to reduce healthcare costs.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

NanoSyrinx is a biotechnology company focused on developing an innovative system for the targeted delivery of therapeutic proteins and peptides directly into the cytosol of cells. By employing synthetic biology techniques, the company aims to create a groundbreaking method for drug delivery that enhances the efficacy, safety, and cost-effectiveness of treatments in the biopharmaceutical sector. This novel approach allows for precise delivery of therapeutic agents, potentially improving treatment outcomes for patients by ensuring that the drugs reach their intended cellular targets.

Atelerix Limited, based in Cambridge, United Kingdom, specializes in the storage and transportation of viable cells and tissues at room temperature. Founded in 2006, the company has developed a patented technology that utilizes alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipping. This innovative approach eliminates the need for cryopreservation, making it easier for customers to use cells and assays immediately upon arrival without the risk of cytotoxicity or damage. Atelerix's technology enhances predictability and reliability in drug discovery models and cell therapies, allowing for the safe storage and transport of suspended and planted cells, as well as tissues and stem cells.

Tropic Biosciences specializes in developing high-performing commercial varieties of tropical crops, utilizing advanced non-GMO gene editing techniques. The company focuses on promoting cultivation efficiencies to address the increasing global food demand while enhancing grower wellbeing and consumer health. By significantly accelerating the breeding process, Tropic Biosciences aims to deliver genetic improvements that empower local farming communities to produce organic crops. Their commitment to sustainable agricultural practices reflects a broader goal of improving environmental outcomes.

MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy.

Ikarovec is a gene therapy company focused on developing early-stage assets for the treatment of common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, including dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By targeting these conditions, Ikarovec seeks to provide effective treatments that restore sight and prevent blindness in patients.

Pencil Biosciences is focused on creating an innovative genome modulation platform that addresses the limitations of existing gene-editing technologies. By developing a programmable tool for genome modulation, the company aims to provide new therapeutic options for patients suffering from rare diseases. This technology is designed to have a broad impact, allowing medical professionals to navigate the complexities of gene editing more effectively. Through its advancements, Pencil Biosciences seeks to enhance the capabilities of gene-editing applications in the medical field.

Cytoseek Limited, a spinout from the University of Bristol, develops innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Established in 2017 and based in Bristol, the company utilizes a novel cell membrane augmentation technology that enhances the functionality of cell therapies. This technology enables targeted tissue delivery and improves cell survivability, potentially increasing the efficacy of treatments. Cytoseek is currently conducting proof of principle studies to validate its approach and is actively seeking partnerships with other cell therapy companies to advance these therapies into clinical applications, ultimately striving to improve human health.

The problem of Needle Stick Injuries (NSI's) is well known throughout medical practice worldwide. However despite nearly two decades of work and legislation in the USA, Europe and other countries, the incidents of NSI's have not fallen as fast or as far as was hoped C-Major Medical was established with the sole purpose of developing a new range of safety devices that will enable, hospitals, clinics and medical practicioners everywhere to prevent NSI's.

Atelerix Limited, based in Cambridge, United Kingdom, specializes in the storage and transportation of viable cells and tissues at room temperature. Founded in 2006, the company has developed a patented technology that utilizes alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipping. This innovative approach eliminates the need for cryopreservation, making it easier for customers to use cells and assays immediately upon arrival without the risk of cytotoxicity or damage. Atelerix's technology enhances predictability and reliability in drug discovery models and cell therapies, allowing for the safe storage and transport of suspended and planted cells, as well as tissues and stem cells.

Procarta Biosystems Ltd., established in 2007 by the scientific founders, Dr. Michael McArthur and Professor Mervyn Bibb, is a spin-out company from the John Innes Centre, Norwich, a world renowned scientific centre of excellence in plant science and microbiology. The company was initially established through Plant Bioscience Ltd (PBL), the internationally regarded group specialising in early stage technology investment and IP management, on behalf of the JIC, the Sainsbury Laboratory and the Biotechnology and Biological Sciences Research Council. Procarta received seed funding in 2008 from the Rainbow and Iceni Seedcorn Funds and is currently headquartered on the Norwich Research Park.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Tropic Biosciences specializes in developing high-performing commercial varieties of tropical crops, utilizing advanced non-GMO gene editing techniques. The company focuses on promoting cultivation efficiencies to address the increasing global food demand while enhancing grower wellbeing and consumer health. By significantly accelerating the breeding process, Tropic Biosciences aims to deliver genetic improvements that empower local farming communities to produce organic crops. Their commitment to sustainable agricultural practices reflects a broader goal of improving environmental outcomes.

Cytoseek Limited, a spinout from the University of Bristol, develops innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Established in 2017 and based in Bristol, the company utilizes a novel cell membrane augmentation technology that enhances the functionality of cell therapies. This technology enables targeted tissue delivery and improves cell survivability, potentially increasing the efficacy of treatments. Cytoseek is currently conducting proof of principle studies to validate its approach and is actively seeking partnerships with other cell therapy companies to advance these therapies into clinical applications, ultimately striving to improve human health.

Glialign is developing a novel cell therapy for peripheral nerve repair — for which current therapies are only successful in less than half of the cases and often can require grafting of a nerve from another part of the body.

MIRICO Ltd., based in Oxford, United Kingdom, specializes in developing advanced analytical instruments for trace gas analysis using unique Laser Dispersion Spectroscopy technology. Founded in 2015, the company focuses on providing high-performance gas sensing solutions that operate effectively in various weather conditions. MIRICO's offerings include stable isotope analyzers for applications such as space exploration and environmental monitoring, as well as real-time monitoring tools that utilize Tuneable Laser Absorption Spectroscopy and Laser Isotope Ratiometer techniques. These products enable industries to monitor emissions continuously and autonomously, facilitating the collection and interpretation of emissions data through a cloud platform. This technology aims to assist organizations in achieving net-zero emissions, improving operational efficiency, and gaining valuable insights into their activities. With a dedicated team of experts, MIRICO continues to set new standards in gas sensing for both industry and research professionals.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

Atelerix Limited, based in Cambridge, United Kingdom, specializes in the storage and transportation of viable cells and tissues at room temperature. Founded in 2006, the company has developed a patented technology that utilizes alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipping. This innovative approach eliminates the need for cryopreservation, making it easier for customers to use cells and assays immediately upon arrival without the risk of cytotoxicity or damage. Atelerix's technology enhances predictability and reliability in drug discovery models and cell therapies, allowing for the safe storage and transport of suspended and planted cells, as well as tissues and stem cells.

Procarta Biosystems Ltd., established in 2007 by the scientific founders, Dr. Michael McArthur and Professor Mervyn Bibb, is a spin-out company from the John Innes Centre, Norwich, a world renowned scientific centre of excellence in plant science and microbiology. The company was initially established through Plant Bioscience Ltd (PBL), the internationally regarded group specialising in early stage technology investment and IP management, on behalf of the JIC, the Sainsbury Laboratory and the Biotechnology and Biological Sciences Research Council. Procarta received seed funding in 2008 from the Rainbow and Iceni Seedcorn Funds and is currently headquartered on the Norwich Research Park.

SFH Oxford Ltd. is a company based in Didcot, United Kingdom, that specializes in developing and marketing innovative healthcare products aimed at improving the treatment of venous leg ulcers. Founded in 2011, the company offers a range of products, including Graducheck, a sensor-based technology that enhances the application of compression bandages, and anatomical focus technology graduated compression socks designed to ensure appropriate compression levels. SFH Oxford also provides K-gel, a wound dressing. By focusing on optimizing care for patients with chronic wounds, the company's solutions aim to enhance healing rates and patient compliance while remaining cost-effective for healthcare systems. SFH Oxford's leadership team brings extensive experience in medical device technology and wound care, and the company is actively conducting clinical and field trials on additional products that show promising results in real-world applications.

The problem of Needle Stick Injuries (NSI's) is well known throughout medical practice worldwide. However despite nearly two decades of work and legislation in the USA, Europe and other countries, the incidents of NSI's have not fallen as fast or as far as was hoped C-Major Medical was established with the sole purpose of developing a new range of safety devices that will enable, hospitals, clinics and medical practicioners everywhere to prevent NSI's.

MyoDOPA is develops a novel therapeutic profile providing efficient treatment.

Camstech Ltd is an early stage company developing novel biochemical sensing technologies. Having graduated from the CERN Business Incubation Centre at Harwell Campus in Oxfordshire, the company is now based at STFC’s Campus Technology Hub, Daresbury Laboratory. Camstech was established in 2014 with a vision to commercialise a novel sensing technology developed by Professor Pankaj Vadgama, initially for life sciences research and subsequently for applications in biotechnology and medical diagnostics.

Cagen is a synthetic biology company.

Pireta has developed a unique free-form process to add durable, conductive, metallic patterns to textiles without changing the fabric feel or performance. Pireta’s technology allows electronic systems to be assembled and interconnected on a wide range of fabrics, enabling a new generation of truly wearable smart garments and e-textiles.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Puraffinity Ltd, founded in 2015 and based in London, specializes in innovative water treatment and purification solutions. The company, which was previously known as Customem Ltd before rebranding in July 2019, has developed a sustainable bio-based adsorbent material designed to effectively remove challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry, Puraffinity's technology allows for the selective capture of micro-pollutants, including pesticides, pharmaceuticals, and hazardous chemicals such as per- and polyfluoroalkyl substances. This capability enables clients to comply with stringent wastewater regulations while contributing to the protection of local ecosystems. Puraffinity is committed to addressing pressing water quality challenges through environmentally sustainable practices.

Cytox Limited specializes in developing products and services aimed at diagnosing and treating neurodegenerative disorders, particularly Alzheimer's disease. The company has created a genetic-based blood test that assesses the risk and diagnosis of Alzheimer's in its early stages, addressing a critical need as the prevalence of the disease rises globally. Cytox's offerings include cellular and genetic assays for identifying cell cycle deficits in patients, along with biomarker and drug-screening services for pharmaceutical companies engaged in clinical trials. The company collaborates with Affymetrix, part of Thermo Fisher Scientific, to enhance its commercial testing capabilities. Founded in 2004 and headquartered in Birmingham, United Kingdom, with additional offices in Manchester and Oxford, Cytox serves pharmaceutical and biotechnology firms, as well as research laboratories involved in clinical research and drug development.

Tropic Biosciences specializes in developing high-performing commercial varieties of tropical crops, utilizing advanced non-GMO gene editing techniques. The company focuses on promoting cultivation efficiencies to address the increasing global food demand while enhancing grower wellbeing and consumer health. By significantly accelerating the breeding process, Tropic Biosciences aims to deliver genetic improvements that empower local farming communities to produce organic crops. Their commitment to sustainable agricultural practices reflects a broader goal of improving environmental outcomes.

Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, founded in 2011. The company has developed a diagnostic platform that utilizes linear dichroism (LD) technology for a variety of applications, including the detection of antibiotic resistance in infections and testing for bacteria that cause food spoilage. This innovative platform enables simultaneous measurement of multiple targets in a single sample, employing various molecular recognition methods. Additionally, Linear Diagnostics offers a handheld reader specifically designed to measure LD signals. The technology provides significant advantages over conventional methods, facilitating rapid point-of-care tests for infectious diseases and addressing challenges related to antibiotic resistance while aiming to reduce healthcare costs.

Nemesis Bioscience is a UK-based biopharmaceutical company focused on reviving the effectiveness of antimicrobial therapies compromised by rising microbial resistance. The company specializes in developing Nemesis Symbiotics, which aim to restore the functionality of existing antibiotics, curb the spread of resistance genes, and safeguard the efficacy of new antibiotics. This innovative technology is applicable across all classes of antibiotics, addressing various resistance mechanisms and bacterial strains. Additionally, Nemesis Bioscience explores other applications such as reducing the toxicity of chemotherapeutics, inactivating virulence factors, and enabling the in vivo synthesis of biofuels and therapeutics. The company has received recognition for its entrepreneurial efforts, including an award from King’s College, Cambridge, and has filed international patent applications for its inventions.

The Electrospinning Company Ltd. specializes in the design, development, and manufacturing of biomaterials for regenerative medical devices and 3D cell culture applications. Based in Didcot, United Kingdom, the company offers a range of products, including aligned fiber scaffolds, removable scaffold discs, and tissue culture plates with hanging inserts. These products are utilized in tissue engineering, regenerative medicine, and drug discovery research. Additionally, the company provides various services, such as scaffold design, sterilization protocol development, regulatory support, and manufacturing for clinical trials. The Electrospinning Company collaborates with academic research groups to create innovative nanofiber solutions that address industrial challenges and enhance medical functions. Founded in 2008, the company also sells its products online, making its advanced biomaterials accessible for in vitro and in vivo applications.

AgPlus Diagnostics have developed a diagnostic platform technology that will deliver against the demanding market requirements of a true quantitative PoC product for use across a wide range of clinical applications.

Keit Ltd. specializes in the design and manufacture of advanced spectrometers and related instruments that operate across a spectrum from ultraviolet to far infrared rays. Established in 2012 and based in Didcot, United Kingdom, the company focuses on innovative applications for its products, which include the measurement of signal levels, vibrations, and various substances in both gas and liquid forms. One of Keit's flagship products is the microFTS®, a compact and rugged Fourier Transform Infrared (FTIR) spectrometer originally developed for space applications. This device sets a new benchmark for real-time liquid-state analyses and serves industries such as pharmaceuticals, chemicals, oil and gas, and food and beverage, where performance in extreme environments is crucial.

MIRICO Ltd., based in Oxford, United Kingdom, specializes in developing advanced analytical instruments for trace gas analysis using unique Laser Dispersion Spectroscopy technology. Founded in 2015, the company focuses on providing high-performance gas sensing solutions that operate effectively in various weather conditions. MIRICO's offerings include stable isotope analyzers for applications such as space exploration and environmental monitoring, as well as real-time monitoring tools that utilize Tuneable Laser Absorption Spectroscopy and Laser Isotope Ratiometer techniques. These products enable industries to monitor emissions continuously and autonomously, facilitating the collection and interpretation of emissions data through a cloud platform. This technology aims to assist organizations in achieving net-zero emissions, improving operational efficiency, and gaining valuable insights into their activities. With a dedicated team of experts, MIRICO continues to set new standards in gas sensing for both industry and research professionals.

Quethera Limited is a gene therapy company based in Canterbury, United Kingdom, founded in 2013. The company specializes in developing innovative treatments for glaucoma and other ophthalmic diseases, particularly aimed at reducing progressive visual loss associated with these conditions. Quethera collaborates with leading experts in the field of glaucoma to design and conduct clinical trials that evaluate the efficacy and safety of its novel therapies, especially for patients who experience accelerated visual field loss. With a strong foundation in gene therapeutic design and development, Quethera is advancing its research pipeline from preclinical testing into clinical development, striving to enhance treatment options for patients suffering from common blinding eye diseases. As of August 2018, Quethera operates as a subsidiary of Astellas Pharma Inc.

Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.

They are a microbiological services provider that provide our clients with a research based approach to microbiological testing, whilst recognising the client’s need for a rapid turnaround and a personalised service. We specialise in bespoke assays with a primary focus on biofilm testing. They appreciate that not all products are appropriate for standard testing assays and therefore we work closely with our clients to develop methods that are suitable for the testing of novel products. They offer an extremely customer focused service that includes regular feedback, consultancy, method development and report writing. In addition we produce conference abstracts and posters based on the data we produce.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases. CHAIN is developing several therapeutic compounds targeted to the gut microbiome in the large intestine that can be delivered by our CADD technology.

NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. It offers a suite of features that can be utilized individually or in conjunction, allowing users to conduct comprehensive checks on individuals, companies, and identification documents. The platform facilitates identity verification across various risk factors and integrates multiple data sources to authenticate businesses, as well as to verify essential documents like passports and visas. By digitizing compliance technologies, NorthRow streamlines onboarding processes and strengthens client due diligence through continuous monitoring of customer profiles, thereby enabling businesses to effectively manage regulatory risks and enhance customer experiences while ensuring compliance with relevant regulations.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Spectral Edge is a technology company focused on developing advanced image processing and enhancement solutions. It utilizes patented image fusion technology combined with deep learning to improve the quality and visibility of images, particularly for individuals with color vision deficiencies. By leveraging the full spectrum of color, Spectral Edge's technology enables the display of multi-modal images that enhance detail and clarity without introducing artifacts. This innovation aims to benefit application developers and enhance the user experience across mass-market devices, allowing for richer and more accessible visual content.

Tokamak Energy is a private company developing and accelerating the development of fusion power. It requires scientific thinking and knowledge, specialist expertise and serious determination. The company offers the smallest and most cost-effective solution. Their unique approach is centred on rapid innovation using the latest materials and technology but building on decades of scientific research and experience. Tokamak Energy focused on spherical tokamaks, pioneered at Culham because these compact devices can achieve a much higher plasma pressure for a given magnetic field than conventional tokamaks. They deploying high-temperature superconducting magnets to control the plasma within its devices. These allow high magnetic fields to be created in the confined dimensions of compact tokamaks, further improving the efficiency of the device. Tokamak Energy was founded in 2009 and is headquartered in Oxfordshire, United Kingdom.

Claresys develops and supplies lens solutions for covert surveillance. Its products include covert pinhole pan/tilt/zoom lenses for mounting on C mount 1/3” sensor cameras; and miniature pinhole camera lenses. The company also designs custom lens for long range surveillance and difficult environments, such as nuclear and high temperature fields. Its optical technologies are applied in various surveillance situations, including close surveillance in buildings and vehicles, and long distance stake-outs.

NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. It offers a suite of features that can be utilized individually or in conjunction, allowing users to conduct comprehensive checks on individuals, companies, and identification documents. The platform facilitates identity verification across various risk factors and integrates multiple data sources to authenticate businesses, as well as to verify essential documents like passports and visas. By digitizing compliance technologies, NorthRow streamlines onboarding processes and strengthens client due diligence through continuous monitoring of customer profiles, thereby enabling businesses to effectively manage regulatory risks and enhance customer experiences while ensuring compliance with relevant regulations.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

Desktop Genetics is an international biotechnology company to helps researchers discover and treat the root genetic causes of human disease. Desktop Genetics is a recognized leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians, and data scientists. The company's tools and technologies are used by organizations all over the world. It enables the work of their pharma, biotech, and academic customers working in drug discovery and functional genomics.

CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga. The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.

They are a microbiological services provider that provide our clients with a research based approach to microbiological testing, whilst recognising the client’s need for a rapid turnaround and a personalised service. We specialise in bespoke assays with a primary focus on biofilm testing. They appreciate that not all products are appropriate for standard testing assays and therefore we work closely with our clients to develop methods that are suitable for the testing of novel products. They offer an extremely customer focused service that includes regular feedback, consultancy, method development and report writing. In addition we produce conference abstracts and posters based on the data we produce.

SFH Oxford Ltd. is a company based in Didcot, United Kingdom, that specializes in developing and marketing innovative healthcare products aimed at improving the treatment of venous leg ulcers. Founded in 2011, the company offers a range of products, including Graducheck, a sensor-based technology that enhances the application of compression bandages, and anatomical focus technology graduated compression socks designed to ensure appropriate compression levels. SFH Oxford also provides K-gel, a wound dressing. By focusing on optimizing care for patients with chronic wounds, the company's solutions aim to enhance healing rates and patient compliance while remaining cost-effective for healthcare systems. SFH Oxford's leadership team brings extensive experience in medical device technology and wound care, and the company is actively conducting clinical and field trials on additional products that show promising results in real-world applications.

Tokamak Solutions UK Ltd. engages in providing technology for fusion neutron source to transmute nuclear waste. The company was founded in 2009 and is based in Abingdon, United Kingdom.